March 3, 2025 - 21:51

Viomi Technology is poised to unveil its financial performance for the second half and the entirety of 2024 on March 25, 2025. The announcement will take place prior to the opening of US markets, providing investors and stakeholders with key insights into the company's fiscal health and operational achievements over the year.
The earnings call is scheduled for 8:00 AM ET, offering a platform for executives to discuss the results in detail. This event is highly anticipated by analysts and investors alike, as it will shed light on the company's growth trajectory, revenue streams, and strategic initiatives undertaken throughout the year.
The results are expected to highlight Viomi's performance in a competitive market, as well as its innovations and advancements in technology. As the date approaches, market participants will be keenly watching for any indications of the company's future direction and potential challenges it may face in the evolving landscape.
October 16, 2026 - 22:08
Dell Technologies (DELL) Lands Core AI Infrastructure Role In New Industrial PlatformDell Technologies has secured a central position in Honeywell`s newly launched Forge Cognition platform, marking another step in the company`s push into industrial artificial intelligence...
October 16, 2026 - 03:28
Russian national extradited to US over alleged scheme to smuggle military-use technology to RussiaA Russian citizen has been handed over to American authorities from Sweden to answer federal charges in an alleged international procurement network that funneled sensitive electronic components to...
October 15, 2026 - 20:09
CDW Canada Recognized by Dell Technologies with Partner Excellence Award for Fifth Straight YearCDW Canada has received the Canadian Partner Excellence Award from Dell Technologies for the fifth year in a row. The recognition highlights the company`s consistent performance in delivering...
October 15, 2026 - 03:16
Tampa General Adopts New Device to Assess Donor Lungs Before TransplantDoctors at Tampa General Hospital are utilizing a device called the XVIVO Lung Perfusion Machine to evaluate donor lungs prior to transplant surgery. The technology allows medical teams to test how...